Outcomes and Review of Periprosthetic Tibial Fractures.


Journal

Orthopedics
ISSN: 1938-2367
Titre abrégé: Orthopedics
Pays: United States
ID NLM: 7806107

Informations de publication

Date de publication:
01 May 2020
Historique:
received: 11 01 2019
accepted: 14 03 2019
pubmed: 23 2 2020
medline: 11 11 2020
entrez: 21 2 2020
Statut: ppublish

Résumé

Periprosthetic fractures around total knee arthroplasties (TKA) are well documented in the literature. Fractures of the tibial side occur least frequently and often pose reconstructive challenges to the treating surgeon. As use of arthroplasty continues to rise, periprosthetic fractures of the tibia will likely become more prevalent. Periprosthetic fracture management is based on recommendations (Mayo classification) made 20 years ago. With newer design technology, the adjuvant use of locking plates in the presence of implant stable periprosthetic tibial fractures (Felix types IIA and IIIA) is unknown. The authors retrospectively reviewed 19 patients who sustained periprosthetic Felix type IIA or IIIA fractures that were treated with operative stabilization using plate and screw constructs. Union rate, time to union, incidence of need for revision on an acute or delayed basis, and restoration of ambulation were investigated. Fourteen patients were followed for the entire course of treatment. Preoperative range of motion was unable to be obtained due to the nature of the injuries. After primary surgical stabilization, 78.6% of the patients obtained successful union of their fracture at a mean of 25 months, but no arthroplasty component revision was necessary in any patient. Three (21.4%) patients required revision surgery, resulting in an overall union rate of 92.9%. Mean time to union in this cohort was 8.4±3.4 months, and the overall complication rate was 28.6%. Treatment of periprosthetic (TKA) tibial fractures carries a relatively high risk of complications and nonunion after primary stabilization, and patients should be counseled accordingly. [Orthopedics. 2020;43(3):182-186.].

Identifiants

pubmed: 32077969
doi: 10.3928/01477447-20200213-02
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

182-186

Informations de copyright

Copyright 2020, SLACK Incorporated.

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH